TET2 and hematologic disorder: This finding, as well as the ubiquitous presence of TET2 mutations in hematological malignancies, indicate that TET2 lesions are mainly ancestral events occurring early in the course of the disease and contribute to the creation of a so-called “mutator phenotype”, by giving to the clone a proclivity for the acquisition of additional molecular lesions [32].